Being a crucial marker of AD, the Aβ1−42 increased the differential performance of Ng between AD and FTLD in both MCI and dementia stages, but more profoundly in the dementia stage with an AUC of 0.90 reflecting an excellent discrimination between AD and FTLD. The gene discussed is NRGN; the disease is dementia.